指南与共识技术与安全泌尿生殖CT

美国放射学会与国家肾脏基金会关于肾病患者使用静脉碘对比剂的共识声明

Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.
指南 / 共识 · Kidney Med · 2020-01-22

该共识指出,静脉碘对比剂相关急性肾损伤的风险被高估,主要因历史研究缺乏足够对照组区分对比剂所致急性肾损伤与对比剂相关急性肾损伤。对于严重肾病患者,对比剂所致急性肾损伤的真实风险仍不确定;对未行维持性透析且存在急性肾损伤或估算肾小球滤过率低于30 mL/min/1.73 m2的患者,推荐静脉生理盐水预防;估算肾小球滤过率30-44 mL/min/1.73 m2的高危患者可由开单医生酌情考虑预防。

要点

  • 静脉碘对比剂相关急性肾损伤风险被高估,需区分对比剂所致与对比剂相关急性肾损伤。
  • 未透析且估算肾小球滤过率低于30 mL/min/1.73 m2或急性肾损伤患者,推荐静脉生理盐水预防。
  • 估算肾小球滤过率30-44 mL/min/1.73 m2的高危患者,可由开单医生酌情考虑预防。

核心结论

  • 静脉碘对比剂所致急性肾损伤的风险被高估,主要因历史研究缺乏足够对照组区分对比剂所致急性肾损伤与对比剂相关急性肾损伤。
  • 严重肾病患者对比剂所致急性肾损伤的真实风险仍不确定。
  • 未行维持性透析且存在急性肾损伤或估算肾小球滤过率低于30 mL/min/1.73 m2的患者,推荐静脉生理盐水预防。
  • 估算肾小球滤过率30-44 mL/min/1.73 m2的高危患者,可由开单医生酌情考虑预防。

研究设计与样本

  • 美国放射学会与国家肾脏基金会发布的共识声明。

诊断标准与关键数值

  • 对比剂所致急性肾损伤指由对比剂给药引起的急性肾损伤,对比剂相关急性肾损伤指与对比剂给药同时发生的急性肾损伤。
  • 未行维持性透析且存在急性肾损伤或估算肾小球滤过率低于30 mL/min/1.73 m2的患者,推荐静脉生理盐水预防。
  • 估算肾小球滤过率30-44 mL/min/1.73 m2的高危患者,可由开单医生酌情考虑预防。

临床应用与阅片要点

  • 阅片及报告时需注意区分对比剂所致急性肾损伤与对比剂相关急性肾损伤,避免高估静脉碘对比剂风险。
  • 对未行维持性透析且存在急性肾损伤或估算肾小球滤过率低于30 mL/min/1.73 m2的患者,推荐静脉生理盐水预防。
  • 对估算肾小球滤过率30-44 mL/min/1.73 m2的高危患者,可由开单医生酌情考虑预防。

局限性

  • 严重肾病患者对比剂所致急性肾损伤的真实风险仍不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Intravenous iodinated contrast media are commonly used with CT to evaluate disease and to determine treatment response. The risk of acute kidney injury (AKI) developing in patients with reduced kidney function following exposure to intravenous iodinated contrast media has been overstated. This is due primarily to historic lack of control groups sufficient to separate contrast-induced AKI (CI-AKI; ie, AKI caused by contrast media administration) from contrast-associated AKI (CA-AKI; ie, AKI coincident to contrast media administration). Although the true risk of CI-AKI remains uncertain for patients with severe kidney disease, prophylaxis with intravenous normal saline is indicated for patients who have AKI or an estimated glomerular filtration rate less than 30 mL/min/1.73 m2 who are not undergoing maintenance dialysis. In individual high-risk circumstances, prophylaxis may be considered in patients with an estimated glomerular filtration rate of 30-44 mL/min/1.73 m2 at the discretion of the ordering clinician.

来源:Kidney Med,查看原文。版权归原作者所有。

引用

  1. Davenport MS, Perazella MA, Yee J, et al. Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Kidney Med. 2020. PMID: 33015613. doi:10.1016/j.xkme.2020.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。